Trusted by Hundreds of Doctors.Refer a Patient Today
Seamless Medical Centers Logo
(409) 213-9575Tap to Call

Advanced Men's Health Care

Prostate Artery Embolization in Lake Charles, LA — Non-Surgical BPH Treatment That Improves Urinary Function

Patients from Lake Charles, LA are seen at our Port Arthur office. Expert, minimally invasive care for men suffering from an enlarged prostate (BPH) — without the need for major surgery.

consultation

Book Your Appointment Today

Same week appointments available

🔒 Your information is 100% private. We never share your data.

Medically reviewed by Zagum Bhatti, M.D. Board-Certified Interventional Radiologist

Last reviewed: July 4, 2026

Patients from Lake Charles, LA are seen at our office located at 3300 Jimmy Johnson Blvd, Suite #130, Port Arthur, TX 77642 — 55 miles away.

Seamless Medical Centers

What Is Prostate Artery Embolization?

Many patients choose prostate artery embolization as a modern option that avoids traditional surgery. By limiting blood supply to the prostate, this procedure helps reduce pressure and gradually shrink the gland, and patients typically experience improved urinary flow over time. At Seamless Medical Centers in Port Arthur, PAE is performed by Dr. Zagum Bhatti, MD, a board-certified interventional radiologist, using advanced imaging and targeted techniques to limit disruption to surrounding tissue.

PAE is a minimally invasive, image-guided procedure. The embolic microsphere device used for it received FDA de novo (Class II) classification for the prostate artery embolization indication in symptomatic BPH in 2017. PAE was added to the 2023 American Urological Association BPH guideline amendment as a conditional recommendation (it "may be offered" after a discussion of risks and benefits), and it is supported by a SIR-led multisociety consensus statement.

PAE is an option for selected patients — not a replacement for TURP when surgery is indicated, and not a cure. Dr. Bhatti confirms whether the procedure is appropriate for you based on prostate size, symptom severity, and vascular anatomy.

Who It's For

Who Can Benefit from Prostate Artery Embolization?

Many men experience prostate enlargement as they age, which can lead to uncomfortable urinary symptoms and daily disruption. For individuals seeking a non-surgical enlarged prostate treatment, prostate artery embolization may provide effective symptom relief. A consultation with Dr. Zagum Bhatti, MD, confirms candidacy based on prostate size, symptom severity, and vascular anatomy.

Urinary Symptoms

Men Experiencing Urinary Symptoms

Men dealing with frequent urination, weak urine flow, or difficulty emptying the bladder may benefit from prostate artery embolization. The non-surgical enlarged prostate treatment helps reduce prostate size and relieve pressure on the urinary tract.

Avoid Surgery

Men Looking to Avoid Surgery

Some patients prefer alternatives to invasive prostate surgery. Prostate artery embolization offers an enlarged prostate non-surgical treatment that focuses on symptom relief while minimizing hospital stays, incisions, and long recovery periods.

Persistent Prostate Enlargement

Men with Persistent Prostate Enlargement

When medications or lifestyle changes fail to control symptoms, prostate artery embolization may help. The non-surgical enlarged prostate treatment targets the blood supply feeding prostate growth, helping reduce pressure and improve bladder function.

Older Adults Managing Prostate Health

Older Adults Managing Prostate Health

Older adults often seek guidance from an enlarged prostate specialist when urinary symptoms affect sleep and daily life. Prostate artery embolization provides a targeted treatment designed to restore comfort and confidence.

Common Symptoms

Prostate Artery Embolization for Lake Charles Men with Enlarged Prostate

An enlarged prostate can create ongoing discomfort and significantly affect a man's quality of life. Many patients experience symptoms that interfere with sleep, daily routines, and overall well-being. Prostate artery embolization offers a minimally invasive approach that focuses on reducing prostate size and relieving pressure on the urinary tract.

checkFrequent urination during the day
checkWaking up multiple times at night to urinate
checkWeak or interrupted urine stream
checkDifficulty starting urination
checkFeeling that the bladder does not fully empty
checkSudden urgency to urinate

For men experiencing these symptoms, prostate artery embolization provides a targeted solution that works by reducing blood flow to the prostate. As the gland gradually shrinks, pressure on the bladder and urethra decreases. Many patients consider this procedure as part of a broader BPH treatment approach when symptoms persist despite medication.

Because the procedure is performed through a small catheter and guided imaging, it typically involves less discomfort and shorter recovery times compared to traditional surgery. Patients often return to normal activities sooner while experiencing lasting improvement in urinary symptoms and overall comfort.

If you're experiencing any of these symptoms, schedule a consultation now →

What to Expect

Safety, Recovery & What to Expect

PAE is an emerging, minimally invasive procedure with a generally favorable safety profile. Understanding recovery, possible side effects, and who may not be a candidate is part of making an informed decision.

Recovery

PAE is an outpatient procedure performed under conscious (moderate) sedation — no general anesthesia. Most men go home the same day through a pinhole entry in the wrist or groin and return to light activity within a few days. Urinary symptoms improve gradually over the following weeks as the prostate shrinks.

Side effects and risks

Most common (temporary, about 1–2 weeks): pelvic or perineal discomfort, urinary frequency or urgency, burning with urination, and sometimes blood in the urine or semen — often grouped as post-PAE syndrome. Less common: temporary urinary retention; seminal-vesicle irritation (hematospermia, reported in up to about 16% of patients); ejaculatory changes that are substantially less frequent than after TURP but not eliminated. Rare: non-target embolization affecting the bladder, rectum, or penile vessels. Major complications are uncommon when the procedure is performed by an experienced interventional radiologist.

Durability

PAE is not a cure. Symptoms can recur, and retreatment (repeat PAE or surgery) is reported in up to roughly 20% of patients at five years; unilateral embolization carries a higher recurrence risk than bilateral.

Who may not be a candidate

PAE is not appropriate for urinary symptoms caused by something other than BPH, or where prostate cancer is suspected, and may be unsuitable with very small prostates, active urinary infection, or vascular anatomy that cannot be safely catheterized. Candidacy is confirmed by Dr. Bhatti.

Surgery-Free Care

Why Men Choose PAE Over Surgery for an Enlarged Prostate

PAE is an option for selected men who want to avoid surgery; it is not a replacement for TURP when surgery is indicated. Dr. Bhatti will help you weigh the options.

checkNo skin incision — pinhole arterial access
checkConscious (moderate) sedation — no general anesthesia
checkSame-day, outpatient procedure
checkLight activity within a few days

PAE vs. TURP Surgery

Prostate Artery Embolization (PAE)TURP (Surgery)
Access / incisionPinhole arterial entry (wrist or groin)No skin incision; tissue resected through the urethra
AnesthesiaConscious (moderate) sedationSpinal or general anesthesia
Hospital staySame-day, outpatientOften 1–2 days
RecoveryLight activity within a few daysAbout 4–6 weeks; urinary catheter for several days
Symptom reliefGradual, over weeksMore immediate
Ejaculatory side effectsLoss of ejaculation much less common — anejaculation ≈16% in a randomized trial; reduced (not absent) ejaculation still reported in ~40% of menLoss of normal ejaculation common — anejaculation ≈52% in the same trial; retrograde ejaculation reported up to ≈65–90% in older series
Erectile functionGenerally preserved; non-target embolization can rarely affect erectionsErectile dysfunction reported in a minority of patients
U.S. regulatory / evidence statusEmbolic device FDA de novo (Class II) classified for PAE (2017); AUA conditional recommendation (2023); evidence maturingLong-established surgical gold standard
Insurance coverageVaries by plan; some payers consider it investigational — verify benefitsGenerally covered
DurabilityRetreatment in up to ~20% at 5 yearsLower retreatment rate

Ejaculation figures are from the randomized PAE-vs-TURP trial (Abt et al., BMJ 2018) and its reassessment (Müllhaupt et al., World J Urol 2020); a matched-pair analysis (Ray et al., 2018) reported retrograde ejaculation in 24.1% after PAE vs 47.5% after TURP. All comparative claims are reviewed and approved by Dr. Bhatti before publishing.

Seamless Medical Centers

Are You a Candidate for PAE?

If you answer "yes" to any of these questions, you may be a candidate for this treatment.

Call Now — (409) 213-9575

Question 1 of 4

Have you ever been diagnosed with Benign Prostatic Hyperplasia?

Prefer to talk? Call (409) 213-9575

Your information is protected under HIPAA. We will never share your data.

Your Consultation

Schedule Your Prostate Artery Embolization Consultation at Our Port Arthur Medical Center

Dr. Zagum Bhatti, MD, reviews your symptoms and imaging to determine whether PAE is a reasonable option for you. During your consultation, your physician will:

  • checkReview your urinary symptoms and IPSS score
  • checkReview prostate imaging and vascular anatomy
  • checkDiscuss whether PAE is appropriate for you
  • checkConfirm candidacy with Dr. Bhatti
  • checkWalk through recovery, risks, and realistic outcomes
  • checkVerify your insurance benefits and coverage for PAE

Got Questions?
Frequently Asked Questions

About Your Physician

Dr. Zagum Bhatti, M.D., board-certified interventional radiologist and founder of Seamless Medical Centers

Zagum Bhatti, M.D.

Board-Certified Interventional Radiologist

Founder & Chief Medical Officer; Interventional Radiologist

Dr. Zagum Bhatti is a board-certified, dual-fellowship-trained interventional radiologist and a former Assistant Professor of Vascular & Interventional Radiology at the University of Texas Health Science Center at Houston (UTHealth). He has dedicated his career to minimally invasive, image-guided procedures that treat serious conditions without open surgery. As Founder and Chief Medical Officer of Seamless Medical Centers, he brings academic-level expertise — including published peer-reviewed research in vascular and interventional radiology — to a community practice in Southeast Texas, making advanced treatments for enlarged prostate, uterine fibroids, knee osteoarthritis, peripheral artery disease, and chronic pain available close to home.

Education & training

  • B.S., Biochemistry University of Wisconsin–Milwaukee (2001–2004)
  • Doctor of Medicine (M.D.) Medical College of Wisconsin (2004–2008)
  • Residency, Diagnostic Radiology Michigan State University College of Human Medicine (2008–2012)
  • Fellowship, Neuroradiology Medical College of Wisconsin (2013–2014)
  • Fellowship, Vascular & Interventional Radiology Rush University Medical Center (Rush Medical College) (2014–2015)

Board certification & licensure

  • Board Certified in Interventional Radiology / Diagnostic Radiology, American Board of Radiology — actively maintained in the ABR Continuing Certification (MOC) program
  • Texas Medical License #Q3852
  • NPI 1053577890

Medical Sources

The clinical information on this page is supported by the following peer-reviewed studies and professional medical society guidance.

  1. AUA BPH Guideline Amendment 2023 (J Urol 2024;211:11–19) — PAE conditional recommendation (Grade C) — 'may be offered'.
  2. FDA de novo classification DEN160040 (2017) — First embolic agent FDA-classified for the PAE indication.
  3. Pisco et al., Radiology — PAE 10-year experience (RSNA, 2020) — Prostate volume reduction (≈39% max) and IPSS improvement.
  4. Abt et al., BMJ 2018;361:k2338 — randomized PAE vs TURP trial — Head-to-head PAE vs TURP, including ejaculatory outcomes.
  5. Müllhaupt et al., World J Urol 2020 — ejaculatory disorders after PAE — Anejaculation ≈16% PAE vs ≈52% TURP; ~40% had diminished ejaculation.
  6. PAE for BPH (J Urol, 2024) — Retreatment up to ~20% at 5 years; gradual symptom relief.
  7. RadioGraphics — PAE indications, technique, complications (RSNA, 2021) — Outpatient, sedation, post-PAE symptoms, complication profile.

Ready to learn more?

Schedule a consultation with Dr. Bhatti to discuss your treatment options and see if this procedure is right for you.

Insurance varies by plan — some payers consider PAE investigational. We verify your benefits and handle prior authorization before treatment.